HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,658,160 | +3.6% | 52,000 | -1.5% | 0.02% | +6.7% |
| Q2 2023 | $4,495,392 | +19.9% | 52,800 | +16.6% | 0.02% | +15.4% |
| Q1 2023 | $3,748,575 | +1078.8% | 45,300 | +906.7% | 0.01% | +1200.0% |
| Q3 2021 | $318,000 | -69.9% | 4,500 | -52.6% | 0.00% | -66.7% |
| Q1 2021 | $1,055,000 | -6.5% | 9,500 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,128,000 | +36.1% | 9,500 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $829,000 | -57.1% | 9,500 | -56.0% | 0.00% | -25.0% |
| Q2 2020 | $1,934,000 | -10.1% | 21,600 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $2,152,000 | +126.3% | 21,600 | +1.9% | 0.01% | +25.0% |
| Q3 2017 | $951,000 | +225.7% | 21,200 | +194.4% | 0.00% | +300.0% |
| Q1 2017 | $292,000 | -53.8% | 7,200 | -67.0% | 0.00% | -66.7% |
| Q2 2016 | $632,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |